Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the

  • value_type as 'ranked' since this provides a very robust analysis method.
  • intercation map as 'high confidence'
  • network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
  • filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.

    • Navigation/Query Panel:
    Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
    Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
    Results: HTML CSV LaTeX Showing element 143 to 192 of 6456 in total 
    Value Type: Ranked
    Interaction Map: High confidence
    Filtered: 1
    
\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
72\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(k), alpha subunit (g(i) alpha-3). [source:swissprot;acc:p08754]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.144\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
336.073\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25802\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
potassium channel-interacting protein 4 isoform 4; calsenilin-like protein. [source:refseq;acc:nm\_147183]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
265.639\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
319.546\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
53.907\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
73\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
junctophilin 3 (junctophilin type 3) (jp-3). [source:swissprot;acc:q8wxh2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
288\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25694\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
kv channel interacting protein 2 isoform 4; a-type potassium channel modulatory protein 2; cardiac voltage gated potassium channel modulatory subunit. [source:refseq;acc:nm\_173193]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
265.632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
319.531\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
53.899\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
74\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
junctophilin 2 (junctophilin type 2) (jp-2). [source:swissprot;acc:q9br39]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
288\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25694\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 65 kda regulatory subunit a, alpha isoform (pp2a, subunit a, pr65-alpha isoform) (pp2a, subunit a, r1-alpha isoform) (medium tumor antigen-associated 61 kda protein). [source:swissprot;acc:p30153]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
189.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
242.453\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
53.383\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
75\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
sphingomyelin phosphodiesterase 2 (ec 3.1.4.12) (neutral sphingomyelinase) (nsmase) (n-smase) (lyso-platelet activating factor- phospholipase c) (lyso-paf-plc). [source:swissprot;acc:o60906]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
288\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25694\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-8 subunit (neuronal voltage- gated calcium channel gamma-8 subunit). [source:swissprot;acc:q8wxs5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
254.693\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.668\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
52.025\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
76\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
db83 protein. [source:swissprot;acc:p57088]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
288\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25694\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-3 subunit (neuronal voltage- gated calcium channel gamma-3 subunit). [source:swissprot;acc:o60359]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
254.693\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
202.668\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
52.025\vspace{3pt}}\\\cline{1-4}\cline{6-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
77\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-2 subunit (neuronal voltage- gated calcium channel gamma-2 subunit). [source:swissprot;acc:q9y698]\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
254.692\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
1.2567\vspace{3pt}}\\\cline{3-3}\cline{6-6}
&&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
52.024\vspace{3pt}}\\\cline{1-2}\cline{4-4}\cline{6-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
78\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-4 subunit (neuronal voltage- gated calcium channel gamma-4 subunit). [source:swissprot;acc:q9ubn1]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
254.691\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
52.023\vspace{3pt}}\\\cline{2-4}\cline{6-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-8 subunit (neuronal voltage- gated calcium channel gamma-8 subunit). [source:swissprot;acc:q8wxs5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
254.693\vspace{3pt}}}&&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.2567\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
79\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-3 subunit (neuronal voltage- gated calcium channel gamma-3 subunit). [source:swissprot;acc:o60359]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-5 subunit (neuronal voltage- gated calcium channel gamma-5 subunit). [source:swissprot;acc:q9uf02]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
254.614\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.646\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
51.968\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
80\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
son protein (son3) (negative regulatory element-binding protein) (nre- binding protein) (dbp-5) (bax antagonist selected in saccharomyces 1) (bass1) (protein c21orf50). [source:swissprot;acc:p18583]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
294.053\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
242.562\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
51.491\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-4 subunit (neuronal voltage- gated calcium channel gamma-4 subunit). [source:swissprot;acc:q9ubn1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
254.691\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.668\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25669\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
81\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 2; homer homolog 3 (drosophila). [source:refseq;acc:nm\_004839]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
252.371\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.016\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
50.355\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-5 subunit (neuronal voltage- gated calcium channel gamma-5 subunit). [source:swissprot;acc:q9uf02]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
254.614\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.646\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25645\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
82\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit 5 (transducin beta chain 5). [source:swissprot;acc:o14775]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
267.636\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
335.359\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25304\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquinone biosynthesis protein coq7 homolog (coenzyme q biosynthesis protein 7 homolog) (timing protein clk-1 homolog). [source:swissprot;acc:q99807]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
252.329\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.004\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
50.325\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
83\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 1b. [source:refseq;acc:nm\_004272]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
252.309\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.998\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
50.311\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma antigen, family d, 4 isoform 1; mage1 protein; mage-e1 protein; maged4 protein. [source:refseq;acc:nm\_030801]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
88.2482\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
110.265\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.24949\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
84\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca3. [source:refseq;acc:nm\_138703]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 3. [source:refseq;acc:nm\_004838]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
252.296\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.995\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
50.301\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
85\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 3 (mage-3 antigen) (antigen mz2-d). [source:swissprot;acc:p43357]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
88.2482\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
110.265\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24949\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sad1/unc-84 protein-like 1. [source:swissprot;acc:o94901]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
296.677\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
247.559\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
49.118\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
86\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dgcr14 protein (digeorge syndrome critical region 14) (es2 protein). [source:swissprot;acc:q96df8]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
335\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
286\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
49\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 11 (mage-11 antigen). [source:swissprot;acc:p43364]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
88.2482\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
110.265\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24949\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
87\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromosome 3p21.1 gene sequence. [source:refseq;acc:nm\_013286]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
249.663\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
298.263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
48.6\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 2 (mage-2 antigen). [source:swissprot;acc:p43356]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
88.2482\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
110.265\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.24949\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
88\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca1. [source:refseq;acc:nm\_020932]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
regulator of g-protein signaling 19 (rgs19) (g-alpha interacting protein) (gaip protein). [source:swissprot;acc:p49795]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
249.663\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
298.263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
48.6\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
89\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 6 (mage-6 antigen) (mage3b). [source:swissprot;acc:p43360]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
88.2482\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
110.265\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24949\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative rna-binding protein 15 (rna binding motif protein 15) (one-twenty two protein). [source:swissprot;acc:q96t37]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
249.663\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
298.263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
48.6\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
90\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
necdin. [source:swissprot;acc:q99608]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
88.2482\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
110.265\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24949\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
regulator of g-protein signaling 20 (rgs20) (regulator of gz- selective protein signaling 1) (gz-selective gtpase-activating protein) (g(z)gap). [source:swissprot;acc:o76081]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
249.663\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
298.263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
48.6\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
91\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen d1 (mage-d1 antigen) (neurotrophin receptor-interacting mage homolog) (pro2292). [source:swissprot;acc:q9y5v3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
88.2482\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
110.265\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24949\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor lbx1. [source:swissprot;acc:p52954]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
249.663\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
298.263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
48.6\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
92\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen f1 (mage-f1 antigen). [source:swissprot;acc:q9hay2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
88.2482\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
110.265\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24949\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mosaic protein lgn. [source:swissprot;acc:p81274]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
249.663\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
298.263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
48.6\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
93\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma antigen, family b, 6. [source:refseq;acc:nm\_173523]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
88.2482\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
110.265\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24949\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
regulator of g-protein signaling 17 (rgs17). [source:swissprot;acc:q9ugc6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
249.663\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
298.263\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
48.6\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
94\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(o), alpha subunit 1. [source:swissprot;acc:p09471]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 4 (mage-4 antigen) (mage-x2) (mage-41). [source:swissprot;acc:p43358]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
88.2482\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
110.265\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.24949\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
95\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 9 (mage-9 antigen). [source:swissprot;acc:p43362]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rap1 gtpase-activating protein 1 (rap1gap). [source:swissprot;acc:p47736]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
249.663\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
298.263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
48.6\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
96\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-3 (activating transcription factor 3). [source:swissprot;acc:p18847]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
201.949\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
153.671\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
48.278\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 8 (mage-8 antigen). [source:swissprot;acc:p43361]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
88.2482\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
110.265\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24949\vspace{3pt}}\\\hline
nd{longtable}

    Legend:
    - Rank is the rank after comparing the two networks
    
 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
    
 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
    
 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
    
 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
    
 - Filtered specifies whether we only included the high confidence microarry measurements or not.
    - http://analysis.yellowcouch.org/